Chicago Partners Investment Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $309K | Buy |
+2,358
| New | +$309K | 0.01% | 819 |
|
|
2025
Q1 | – | Sell |
-2,445
| Closed | -$369K | – | 940 |
|
|
2024
Q4 | $369K | Buy |
2,445
+1,015
| +71% | +$153K | 0.01% | 590 |
|
|
2024
Q3 | $262K | Buy |
1,430
+22
| +2% | +$4.03K | 0.01% | 660 |
|
|
2024
Q2 | $298K | Sell |
1,408
-117
| -8% | -$24.8K | 0.01% | 593 |
|
|
2024
Q1 | $295K | Sell |
1,525
-85
| -5% | -$16.4K | 0.01% | 574 |
|
|
2023
Q4 | $398K | Sell |
1,610
-40
| -2% | -$9.89K | 0.02% | 476 |
|
|
2023
Q3 | $418K | Buy |
1,650
+50
| +3% | +$12.7K | 0.02% | 445 |
|
|
2023
Q2 | $434K | Sell |
1,600
-32
| -2% | -$8.69K | 0.02% | 449 |
|
|
2023
Q1 | $478K | Sell |
1,632
-155
| -9% | -$45.4K | 0.03% | 388 |
|
|
2022
Q4 | $521K | Buy |
1,787
+33
| +2% | +$9.62K | 0.03% | 365 |
|
|
2022
Q3 | $499K | Buy |
1,754
+363
| +26% | +$103K | 0.04% | 335 |
|
|
2022
Q2 | $299K | Buy |
1,391
+71
| +5% | +$15.3K | 0.02% | 440 |
|
|
2022
Q1 | $258K | Buy |
+1,320
| New | +$258K | 0.02% | 448 |
|
|
2018
Q4 | – | Sell |
-6
| Closed | -$2K | – | 386 |
|
|
2018
Q3 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 987 |
|
|
2017
Q2 | – | Sell |
-105
| Closed | -$29K | – | 647 |
|
|
2017
Q1 | $29K | Buy |
105
+5
| +5% | +$1.38K | 0.01% | 370 |
|
|
2016
Q4 | $28K | Buy |
100
+50
| +100% | +$14K | 0.01% | 349 |
|
|
2016
Q3 | $16K | Buy |
+50
| New | +$16K | 0.01% | 379 |
|
|
2015
Q2 | – | Sell |
-31
| Closed | -$11K | – | 444 |
|
|
2015
Q1 | $11K | Buy |
31
+6
| +24% | +$2.13K | ﹤0.01% | 339 |
|
|
2014
Q4 | $9K | Buy |
+25
| New | +$9K | ﹤0.01% | 371 |
|